Medical Device News Magazine

Datos Health Partners With Vaica Medical

Augments Remote Care Platform With Medication Management Capabilities

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Datos Health, a leader of remote care automation, and Vaica Medical, a leading provider of medication adherence solutions, today announced a partnership to include medication adherence information as part of Datos’ offering of analyzed data relating to the overall status of patients’ health and wellbeing.

The first implementation for this collaboration began in the third quarter of 2020 with the Psychiatry Division at Sheba Medical Center, as part of an overall program to introduce comprehensive remote psychiatric care (i.e. telemedicine) to the home environment.

The partnership between Datos Health and Vaica Medical addresses the general lack of patient adherence to treatments and the challenge this poses by negatively impacting patients’ recovery, resulting in a greater burden on healthcare providers. Vaica’s comprehensive medication adherence technology, synchronized with patient-generated data collated and evaluated by Datos’ remote care platform, enables clinicians to stay up-to-date regarding the status of patients, facilitating enhanced decision making. Concurrently, the Datos mobile app enables more personalized care by ensuring patients are well-informed, take greater responsibility for their own treatments, and remain engaged with their care providers.

“Partnering with Vaica allows us to complement our remote care offerings with a new dimension, furthering our goal of advancing proactive and personalized care through increased patient engagement,” said Uri Bettesh, CEO and Founder of Datos Health. “We look forward to continually expanding our capabilities to support hospitals through remote care initiatives that can ultimately improve patient outcomes.”

Patients found to be suitable for home hospitalization received a specialized kit to maintain continuous contact and online follow-ups with clinical staff. Monitoring devices collate all clinical data for analysis, while the Datos mobile app facilitates video calls with physicians and nurses available on a 24/7 basis. The Datos app further alerts care teams of deviation from routine, including sleep disturbance, changes in mood and – through inclusion of Vaica’s core technology – medication adherence.

“The fundamental goal of this partnership is to improve medication adherence rates among patients through remote care technology, setting the foundation for improved patient-clinician engagement and better-informed treatment,” said Tomer Gofer, CEO for Vaica Medical. “Through our collaboration with Datos, care teams will be able to not only monitor patient adherence to medication in real-time, but also correlate this new layer of information with additional data to fully benefit both patients and providers.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”